Search Results - "van Erpecum, K."

HLA-DRB103:01 and HLA-DRB104:01 modify the presentation and outcome in autoimmune hepatitis type-1 by van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L, Bouma, G

“…The classical human leukocyte antigen (HLA)-DRB1*03:01 and HLA-DRB1*04:01 alleles are established autoimmune hepatitis (AIH) risk alleles. To study the…”
Get full text

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes by Baven‐Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., de Man, R. A., van Erpecum, K. J., Lamers, M. M. H., Drenth, J. P. H., van den Berg, A. P., Beuers, U. H., den Ouden, J., Koek, G. H., van Nieuwkerk, C. M. J., Bouma, G., Brouwer, J. T., van Hoek, B.

“…Aliment Pharmacol Ther 2011; 34: 335–343 Summary Background  Treatment failure occurs in 20% of autoimmune hepatitis patients on prednisolone and azathioprine…”
Get full text

Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease by van Dijk, A. M., de Vries, M., El-Morabit, F., Bac, S. T., Mundt, M. W., van der Schuit, L. E., Hirdes, M. M. C., Kara, M., de Bruijne, J., van Meer, S., Kaasjager, H. A. H., de Valk, H. W., Vleggaar, F. P., van Erpecum, K. J.

“…Background Data on effects of intra-gastric balloon (IGB) on metabolic dysfunction-associated steatotic liver disease (MASLD) are scarce, in part with…”
Get full text

Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era by Berden, F A C, Kievit, W, Baak, L C, Bakker, C M, Beuers, U, Boucher, C A B, Brouwer, J T, Burger, D M, van Erpecum, K J L, van Hoek, B, Hoepelman, A I M, Honkoop, P, Kerbert-Dreteler, M J, de Knegt, R J, Koek, G H, van Nieuwkerk, C M J, van Soest, H, Tan, A C I T L, Vrolijk, J M, Drenth, J P H

“…A new era for the treatment of chronic hepatitis C is about to transpire. With the introduction of the first-generation protease inhibitors the efficacy of…”
Get full text

ELF-test less accurately identifies liver cirrhosis diagnosed by liver stiffness measurement in non-Asian women with chronic hepatitis B by Harkisoen, S, Boland, G.J, van den Hoek, J.A.R, van Erpecum, K.J, Hoepelman, A.I.M, Arends, J.E

“…Highlights • ELF test is a non-invasive test to assess liver fibrosis in chronic liver diseases. • ELF test poorly discriminated severe fibrosis and cirrhosis…”
Get full text

Indomethacin enhances bile salt detergent activity : Relevance for NSAIDs-induced gastrointestinal mucosal injury by PETRUZZELLI, M, MOSCHETTA, A, RENOOIJ, W, DE SMET, M. B. M, PALASCIANO, G, PORTINCASA, P, VAN ERPECUM, K. J

“…Gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) is partly independent from cyclooxygenase inhibition, possibly related to increased…”
Get full text

Current treatments of primary sclerosing cholangitis by Vacca, M, Krawczyk, M, Petruzzelli, M, Sasso, R C, van Erpecum, K J, Palasciano, G, van Berge-Henegouwen, G P, Moschetta, A, Portincasa, P

“…Primary Sclerosing Cholangitis (PSC) is a chronic cholestatic disease characterized by hepatic inflammation and obliterative fibrosis, resulting in both intra-…”
Get more information

Fatal N-butyl-2-cyanoacrylate pulmonary embolism after sclerotherapy for variceal bleeding by van Beek, A P, van Erpecum, K J

Get more information

Treatment of chronic hepatitis B virus infection : Dutch national guidelines by BUSTER, E. H. C. J, VAN ERPECUM, K. J, SCHALM, S. W, ZAAIJER, H. L, BROUWER, J. T, CELDERBLOM, H. C, DE KNEGT, R. J, MINKE BAKKER, C, REESINK, H. W, JANSSEN, H. L. A

“…The development of this guideline was initiated and coordinated by the Netherlands Association of Gastroenterologists and Hepatologists (Nederlandse Vereniging…”
Get full text

The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection by BUSTER, E. H. C. J, BAAK, B. C, KOEK, G. H, VAN NIEUWKERK, K. M. J, SOEST, H. Van, VAN DER SPEK, B. W, TAN, A. C. I. T. L, VROLIJK, J. M, JANSSEN, H. L. A, BAKKER, C. M, BEUERS, U. H. W, BROUWER, J. T, DRENTH, J. P. H, VAN ERPECUM, K. J, HOEK, B. Van, HONKOOP, P, KERBERT-DRETELER, M. J

“…In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national…”
Get full text

Severe impairment of postprandial cholecystokinin release and gall‐bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR by Moschetta, A., Stolk, M. F. J., Rehfeld, J. F., Portincasa, P., Slee, P. H. TH. J., Koppeschaar, H. P. F., Van Erpecum, K. J., Vanberge‐Henegouwen, G. P.

“…Background: Acromegalic patients treated three times daily with subcutaneous injections of the somatostatin analogue octreotide frequently develop gallstones,…”
Get full text

Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients by van Vlerken, L. G., Huisman, E. J., van Soest, H., Boland, G. J., Drenth, J. P. H., Siersema, P. D., Burger, D. M., van Erpecum, K. J.

“…Twenty to fifty per cent of patients with chronic hepatitis C (CHC) experience nonresponse to current antiviral therapy, which may relate in part to ribavirin…”
Get full text

Treatment of chronic hepatitis C virus infection : Dutch national guidelines by DE BRUIJNE, J, BUSTER, E. H. C. J, REESINK, H. W, GELDERBLOM, H. C, BROUWER, J. T, DE KNEGT, R. J, VAN ERPECUM, K. J, SCHALM, S. W, BAKKER, C. M, ZAAIJER, H. L, JANSSEN, H. L. A

“…The development of this guideline was initiated and coordinated by the Netherlands Association of Gastroenterologists and Hepatologists (Nederlandse Vereniging…”
Get full text

Valproic acid-induced DRESS syndrome with acute liver failure by VAN ZOELEN, M. A. D, DE GRAAF, M, DIJK, M. R. Van, BOGTE, A, ERPECUM, K. J. Van, ROCKMANN, H, MAARSCHALK-ELLERBROEK, L. J

Get full text

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non‐invasive assessment of liver fibrosis using transient elastography by POSTHOUWER, D., MAUSER‐BUNSCHOTEN, E. P., FISCHER, K., VAN ERPECUM, K. J., DE KNEGT, R. J.

“…Background: Many patients with bleeding disorders have been infected with the hepatitis C virus (HCV), mainly with genotype 1. Antiviral treatment is only…”
Get full text

Acute idiopathic pancreatitis: does it really exist or is it a myth? by van Brummelen, S E, Venneman, N G, van Erpecum, K J, VanBerge-Henegouwen, G P

“…Acute pancreatitis is a severe disease with considerable morbidity and mortality. Gallstones and alcohol abuse are the most frequent causes (75% of patients)…”
Get full text

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease by Gadaleta, Raffaella M, van Erpecum, Karel J, Oldenburg, Bas, Willemsen, Ellen C L, Renooij, Willem, Murzilli, Stefania, Klomp, Leo W J, Siersema, Peter D, Schipper, Marguerite E I, Danese, Silvio, Penna, Giuseppe, Laverny, Gilles, Adorini, Luciano, Moschetta, Antonio, van Mil, Saskia W C

“…Inflammatory bowel disease (IBD) is characterised by chronic intestinal inflammation, resulting from dysregulation of the mucosal immune system and compromised…”
Get more information

Real-life costs of hepatitis C treatment by HELSPER, C. W, HELLINGA, H. L, ESSEN, G. A. Van, DE WIT, G. A, BONTEN, M. J. M, ERPECUM, K. J. Van, HOEPELMAN, A. I. M, RICHTER, C, DE WIT, N. J

“…Hepatitis C virus infection is a serious health threat in today's society. Improved identification strategies have increased the number of patients undergoing…”
Get full text

Gallstones: an intestinal disease? by VAN ERPECUM, K J, VAN BERGE-HENEGOUWEN, G P

“…Current evidence suggests that impaired intestinal motility may facilitate gallstone formation by influencing biliary deoxycholate levels or by modulating…”
Get full text

Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury by Venneman, N. G., Petruzzelli, M., van Dijk, J. E., Verheem, A., Akkermans, L. M. A., Kroese, A. B. A., van Erpecum, K. J.

“…Background  Indomethacin (Indo) exerts local toxic effects on small intestinal mucosa, possibly in association with hydrophobic bile salts. We investigated the…”
Get full text